Michel Demeule - Theratechnologies (Canada)

Guylaine Roy, Pratik Kadekar,Lynn Marie Douglas, Maude Frappier,Jean-Christophe Currie, Jess Dhillon, Gregory Cesarone, Richard Siderits, Karen Kirchner,Michel Demeule,Christian Marsolais

Cancer Research（2023）

Cited1Views0Bibtex

Supplemental Figure 1 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, is Efficacious Against HER2-Positive Intracranial Tumors in Mice

Anthony Regina,Michel Demeule,Sasmita Tripathy,Simon Lord-Dufour,Jean-Christophe Currie,Mustapha Iddir,Borhane Annabi,Jean-Paul Castaigne,Jean E. Lachowicz

openalex（2023）

Cited0Views0Bibtex

Supplemental Figure Legends from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, is Efficacious Against HER2-Positive Intracranial Tumors in Mice

Anthony Regina,Michel Demeule,Sasmita Tripathy,Simon Lord-Dufour,Jean-Christophe Currie,Mustapha Iddir,Borhane Annabi,Jean-Paul Castaigne,Jean E. Lachowicz

openalex（2023）

Cited0Views0Bibtex

Supplemental Figure 2 from ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, is Efficacious Against HER2-Positive Intracranial Tumors in Mice

Anthony Regina,Michel Demeule,Sasmita Tripathy,Simon Lord-Dufour,Jean-Christophe Currie,Mustapha Iddir,Borhane Annabi,Jean-Paul Castaigne,Jean E. Lachowicz

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn